Punctate inner choroidopathy in common variable immunodeficiency associated with a pathogenic variant in the tumour necrosis factor receptor superfamily 13b (TNFRSF13B) gene - Case report and review of the literature.


Journal

Clinical immunology (Orlando, Fla.)
ISSN: 1521-7035
Titre abrégé: Clin Immunol
Pays: United States
ID NLM: 100883537

Informations de publication

Date de publication:
10 2023
Historique:
received: 06 03 2023
revised: 16 08 2023
accepted: 28 08 2023
medline: 2 10 2023
pubmed: 1 9 2023
entrez: 31 8 2023
Statut: ppublish

Résumé

Common variable immunodeficiency (CVID) has been recognised as the most common primary immunodeficiency in adulthood, and is characterised by increased susceptibility to infection, autoimmunity and increased risk of malignancies. Although ocular manifestations are not common in CVID, rare associated inflammatory eye conditions have been reported including submacular choroiditis. To report a case of punctate inner choroidopathy in a patient with common variable immunodeficiency. A 40-year-old lady with CVID and associated autoimmune thrombocytopenia, who was treated with immunoglobulin replacement and Eltrombopag, experienced gradually deteriorating right eye vision. Fundal examination and optical coherence tomography (OCT) revealed right multifocal retinal choroidal lesions consistent with a diagnosis of unilateral punctate inner choroidopathy (PIC) with secondary choroidal neovascularisation (CNV). Anti-VEGF injections led to stabilised fundal appearances. Genetic testing revealed a heterozygous sequence change c.260 T > Ap.(IIe87Asn), pathogenic variant in the Tumour Necrosis Factor Superfamily 13B (TNFRSF13B) gene, which is reported as being associated with ∼10% of CVID cases. Autoimmunity may be the dominant clinical presenting feature of CVID. Punctuate inner choroidopathy is an idiopathic inflammatory chorioretinopathy, and to the best of our knowledge, has not been previously reported in CVID. A better understanding of the molecular bases of autoimmune diseases in CVID may provide novel therapeutic targets for autoimmune diseases in this patient population.

Sections du résumé

BACKGROUND
Common variable immunodeficiency (CVID) has been recognised as the most common primary immunodeficiency in adulthood, and is characterised by increased susceptibility to infection, autoimmunity and increased risk of malignancies. Although ocular manifestations are not common in CVID, rare associated inflammatory eye conditions have been reported including submacular choroiditis.
OBJECTIVE
To report a case of punctate inner choroidopathy in a patient with common variable immunodeficiency.
CASE PRESENTATION
A 40-year-old lady with CVID and associated autoimmune thrombocytopenia, who was treated with immunoglobulin replacement and Eltrombopag, experienced gradually deteriorating right eye vision. Fundal examination and optical coherence tomography (OCT) revealed right multifocal retinal choroidal lesions consistent with a diagnosis of unilateral punctate inner choroidopathy (PIC) with secondary choroidal neovascularisation (CNV). Anti-VEGF injections led to stabilised fundal appearances. Genetic testing revealed a heterozygous sequence change c.260 T > Ap.(IIe87Asn), pathogenic variant in the Tumour Necrosis Factor Superfamily 13B (TNFRSF13B) gene, which is reported as being associated with ∼10% of CVID cases.
CONCLUSION
Autoimmunity may be the dominant clinical presenting feature of CVID. Punctuate inner choroidopathy is an idiopathic inflammatory chorioretinopathy, and to the best of our knowledge, has not been previously reported in CVID. A better understanding of the molecular bases of autoimmune diseases in CVID may provide novel therapeutic targets for autoimmune diseases in this patient population.

Identifiants

pubmed: 37652172
pii: S1521-6616(23)00511-9
doi: 10.1016/j.clim.2023.109748
pii:
doi:

Substances chimiques

TNFRSF13B protein, human 0
Transmembrane Activator and CAML Interactor Protein 0

Types de publication

Review Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

109748

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Auteurs

Hiba Salih (H)

Clinical Immunology Registrar, Royal Infirmary of Edinburgh, Immunology, NHS Lothian, Edinburgh, UK. Electronic address: hiba.salih@nhs.scot.

Kelvin Cheng Kah Wai (KCK)

Opthalmology Registrar, Princess Alexandra Eye Pavilion, Opthalmology, NHS Lothian, Edinburgh, UK.

Justin McKee (J)

Consultant Medical Opthalmologist, Princess Alexandra Eye Pavilion, Opthalmology, NHS Lothian, Edinburgh, UK.

Charu Chopra (C)

Clinical Immunology Registrar, Royal Infirmary of Edinburgh, Immunology, NHS Lothian, Edinburgh, UK; Consultant Clinical Immunology, Royal Infirmary of Edinburgh, Immunology, NHS Lothian, Edinburgh, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH